Skip to main content
Equibles

INTECH INVESTMENT MANAGEMENT LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1086318 WEST PALM BEACH, FL
Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,047,552
+$345,574 QoQ
Shares Held
41,291
+32.9% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 254 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

INTECH INVESTMENT MANAGEMENT LLC holds $75,544,237 across 33 Drug Manufacturers - Specialty & Generic names. PCRX ranks #14 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 474,709 $16,083,140
2 UTHR
UNITED THERAPEUTICS Corp
 29,102 $15,768,335
3 NBIX
Neurocrine Biosciences Inc
 63,662 $10,729,593
4 LNTH
Lantheus Holdings, Inc.
 44,458 $4,932,170
5 INDV
Indivior Pharmaceuticals, Inc.
 107,818 $4,423,772
6 ZTS
Zoetis Inc.
 60,226 $4,327,839
7 ANIP
Ani Pharmaceuticals Inc
 35,018 $2,898,790
8 ALKS
Alkermes plc.
 40,552 $2,124,924

All Filings in PCRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,047,552 41,291
2026-03-31 $701,978 31,061
2025-12-31 $4,314,584 166,715
2025-09-30 $1,626,653 63,122
2025-06-30 $525,441 21,985
2025-03-31 $546,327 21,985
2024-12-31 $319,658 16,967
2024-09-30 $191,375 12,716